Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Vildagliptin + Metformin & Type 2 diabetes (T2D), there is an EMA approval for vildagliptin + metformin as a fixed‑dose combination for type 2 diabetes (T2D); however, there is currently no FDA‑approved vildagliptin‑containing product (including vildagliptin + metformin) marketed in the United States.
Vildagliptin / Metformin hydrochloride Accord | European Medicines Agency (EMA)
The randomized clinical phase IV treatment trial NCT01528254 revealed that early in…